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Abstract  
 
In many developing countries, a large percentage of the population lacks access to adequate              
healthcare. This is especially true in India where close to 70% of the population lives in rural                 
areas and has little to no access to hospitals or clinics. People living in rural India often times                  
cannot afford to pay to see a doctor should they need to make the journey to a hospital.                  
Telemedicine, a breakthrough in the past couple decades, has broken down the barrier between              
the patient and the physician. It has slowly been implemented in India to make doctors more                
available to patients through the use of video conferences and other forms of communication. 
 
A compact and affordable kit has been developed that will be used to take a patient’s blood                 
pressure, heart rate, blood glucose concentration and oxygen saturation. Our most novel            
contribution is the non-invasive glucose sensor that will use a near-infrared LED and photodiode              
in the patient’s earlobe. Currently millions of diabetics do this by pricking their finger. By               
wirelessly sending data results from the vital sign kit, the first essential part of a treatment can be                  
carried out via wireless communication, saving the doctor and patient time and money.  
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Chapter 1: Introduction 
 
1.1 Background 
In many developing countries, a large percentage of the population lacks access to adequate              
healthcare. This is especially true in India where close to 70% of the population lives in rural                 
areas and has little to no access to hospitals or clinics. In addition, the doctor to patient ratio is                   
0.7 to 1000 [1], meaning a large percentage of the population in India has no access to a doctor                   
or clinic [2]. This means that people living in rural India are left without access to a nearby                  
hospital and often times cannot afford to pay to see a doctor if they do make the journey to a                    
hospital [3]. Telemedicine, a breakthrough in the past couple decades, has broken down the              
barrier between the patient and the physician. Telemedicine has slowly been implemented in             
India to make doctors more available to patients through the use of video conferences and other                
forms of communication. According to Amrita Pal, telemedicine is highly needed for India’s             
rural population. Currently, patients usually have a late diagnosis of their illness, cannot get to               
their care provider in time, and do not get the treatment they need from the right providers [4].                  
However, a shortcoming of this is that the doctor still has no direct access to a patient's                 
information, other than descriptions, x-rays, etc. 
 
1.2 Project Goal 
Our objective is to develop a kit equipped with sensors that will be used to take a patient’s vital                   
signs, such as blood pressure, heart rate, blood glucose concentration, and blood oxygen             
saturation. It will be inexpensive and accessible to people in rural areas of developing countries.               
In such scenarios, this device would replace the first steps of any standard medical checkup.               
Instead of traveling all the way to a hospital to have baseline vitals measured, you would                
measure them with this device, and send them to a physician for review to help determine                
whether an in-person appointment is necessary. This frugal device gives under-resourced           
families the opportunity to take care of their health and live a better life. Although our device                 
could be applicable in almost any region with lack of access to healthcare, we believe India                
would be the region that would benefit the most from our device, which is why most of our                  
research and project will focus with India in mind. 
  
By having a medical kit that takes many important vital signs, even people who do not have                 
insurance or easy access to a hospital will be able to monitor their own vital signs and those of                   
their family members. This solution is better than others currently available because it is much               
smaller, cheaper, and more intuitive in design and use. Current devices include carts that are used                
in most hospitals here in the US, that are about three feet tall, and cost in the range of hundreds                    
to one thousand dollars. An example of this commercial monitor is the Welch Allyn Vital Sign                
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Monitor that is commonly used in hospitals, at the price of $300 [4]. There are a number of other                   
available devices, but they are expensive, and generally only have one or two types of sensors.                
FDA approved pulse oximeters only have one function of measuring oxygen saturation, yet they              
cost about $100. The proposed device is targeted to cost no more than $150, will contain at least                  
four sensor types, and be connectable to a mobile device such that data can be sent wirelessly to                  
a physician via Wi-Fi or SMS. Communities can share multiple vital sensor kits and split costs                
accordingly to make the device even more affordable. We strongly believe that by making this               
device low-cost and simple to use for developing countries, communities and families will be              
much happier and healthier because they will be able to get the medical attention they need from                 
doctors without having to have the financial burden of paying for multiple hospital visits and               
transportation costs. 
  
1.3 Review and Critique of Literature 
Device from 2015-16 Senior Design 
The device produced by last year’s team had similar goals to this year’s team, with the exception                 
of an additional parameter. Their device focused on blood pressure, pulse oximetry, and heart              
rate measurements [6]. While the blood pressure measurements were relatively accurate, there            
was notable error with the other two parameters, especially the pulse oximeter, which retained an               
error of 13% relative to commercial pulse oximeters. This team was also unable to reach the                
stage of connecting to a mobile device for sending data. The final prototype of last year’s team’s                 
device is shown in figure 1. As stated above, this year’s team seeks to utilize the prototype from                  
last year’s team as a baseline, and seeks to improve it by: 
● Adding additional sensor (blood glucose monitoring) 
● Changing the Arduino Mega microcontroller and breadboard to a PCB method 
● Integrating device with mobile system for sending data 
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Figure 1-1: Last Year’s Team’s Final Prototype 
  
With these additional sensors added to the device, it will serve as a more accurate diagnostic                
tool, such that physicians can get a better idea of the condition of the patient, to better determine                  
the best intervention without requiring the patient to necessarily make an expensive and tedious              
journey all the way to a hospital. 
 
Without yet having spoken directly with the potential users of this device, research has been               
done into rural parts of India, to examine as a case study what sorts of illnesses are prevalent, in                   
order to determine what sorts of sensors would be of greatest use to the users. For example, were                  
cardiovascular disease to be very rare in rural India, it would be a waste of resources to make                  
efforts to include a blood pressure sensor in the device, as that is the primary function of that                  
particular sensor[7]. Upon examination, there is prevalence of lung disease, cardiovascular           
illnesses, and diabetes in India, which lead to our inclusion of the blood pressure sensor for the                 
cardiovascular illnesses, the pulse oximeter for lung disease, and a blood glucose meter for the               
diabetes.[8] 
 
1.4 Sensor Designs 
Commercially available vital sensor devices are quite expensive, with accurate and reliable            
individual sensors each costing well over one hundred USD each. There are also devices, such as                
those currently used in hospitals, which are multi-sensor “carts” which cost over one thousand              
USD for the cart. For this reason, it was decided by this year’s team that in order to make a more                     
frugal device, different designs would be needed to reduce the overall cost of the device, while                
still maintaining accuracy and efficiency. This involves learning the inner workings of how             
commercial sensor devices, and replicating these functions with less expensive parts, and making             
up for discrepancies in more expensive technologies with simplistic yet effective hardware and             
software enhancing and filtering systems. 
  
1.4.1 Proof of Concept Sensors 
Included among the sensors that this year’s team is connecting to the device is the non-invasive                
blood glucose meter, which is not yet commercially available. However, due to the high demand               
for a sensor of this kind and its relevance to rural India, it was determined that this sensor would                   
be very useful to include in the device. 
Given the fact that this sensor is not commercially available, it is to be constructed from proof of                  
concept designs found in various journals. For the non-invasive blood glucose meter,            
near-infrared light functions in a way that is similar to the pulse oximeter, which is to use light                  
transmittance as a means of measurement, as the transmitted light is linearly correlated to the               
blood glucose levels [9]. Given the prototype-nature of this sensor, it may be prone to error.                
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However, should they be functional, they would serve as incredible tools to serve the rural               
communities of India. 
  
1.4.2 Non-Invasive Glucose Meter 
As of 2008, there were thirty-nine companies doing active research and development with the              
purpose of producing a functional, commercially viable non-invasive glucose monitoring          
system[10]. Of these thirty-nine, nineteen were focused on utilizing some form of spectroscopy,             
with eight of them pursuing near-infrared spectroscopy. There is also a wide range of parts of the                 
body focused upon for the measurement of the blood glucose concentrations, ranging from tears              
measured by contact lenses to forearm skin. As of 2016, there are at least two companies that are                  
in the process of receiving FDA approval for their devices[11]. It appears that this technology is                
not too far from the market, but these devices will likely be very expensive, due to the extremely                  
high demand for a non-invasive glucose meter. 
  
1.4.3 Telemedicine Multi-Sensors 
Today, there are no telemedicine multi-sensors of the variety that we are producing on the               
market. However, there is one company that is expected to receive FDA approval in 2017 called                
MedWand[12], which is an all-in-one sensor that measures heart rate, blood oxygen saturation,             
temperature, and serves as a digital stethoscope and camera as well. This device has a very                
similar mission to that of our device, to save the patient time and money, and provide data to a                   
doctor that is engaging with telemedicine. However, the MedWand is expected to be more              
expensive than our device, and also does not come with a method for measuring blood pressure                
or blood glucose, although it has bluetooth capabilities that allow for connection to bluetooth              
enabled blood glucose meters and blood pressure monitors. The lack of these sensors would              
further increase the price of the device if one was to purchase additions for the MedWand, and                 
requires the use of a computer or tablet. This involves a bit of an access barrier, as there are                   
fewer people that have regular access to a laptop or tablet than there are those who have                 
smartphones. This is particularly true in areas outside the United States, such as rural India,               
which has a well established cell phone infrastructure, but less access to computers. 
 
1.5 Expected Results 
The end goal of the product is to be able to successfully measure blood pressure, blood oxygen                 
saturation, heart rate, and blood glucose concentration of a patient within 5% error. There are               
two physical sensors to be built that are to be used to gather the data for the patient in question.                    
The above four vitals signs are to be measured with an ear clamp sensor and a blood pressure                  
cuff. The measured results are to be measured and displayed on an external device, such as a                 
mobile device or computer. The expected results we hope to gain are accurate readings of the                
four vital signs that are able to be read easily by the user. We expect to make a fairly easy to use                      
device that is intuitive to use by the user. 
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1.6 Backup Plan: 
For the Oximeter, we have ensured that if our ear lobe clamp in development does not work, we                  
can quickly modify the PCB to at least be able to connect and use a Nellcor DS-100A sensor.                  
The Nellcor DS-100A, is a finger clamp that we can use to implement an oximeter with our                 
designed PCB. By measuring at least 2 of the vital signs desired and we can move forward with                  
the data transmission part of the project. At the same, we could use a breadboard and Arduino                 
Uno board to altogether create a different circuit for our sensor, in case there is a small but                  
salvageable error in our design. While it would be expensive to acquire a Integrated Analog               
Front End for Pulse Oximeters (AFE4490), we also have that option, which would allow us to                
replace our overall circuits and use the AFE4490 to drive the LEDs for the Oximeter and                
possibly the Blood Glucose sensor. The back up plan for the Blood Pressure Sensor is to use a                  
breadboard and Arduino Uno combination. 
  
1.7 Significance 
The successful completion and implementation of this project will bring further scientific            
progress to making healthcare affordable. In addition, a major component of this project is that               
blood glucose will be able to be detected non-invasively, which will completely transform the              
way diabetics monitor their blood sugar levels. This device that affordably measures the             
important vital signs [13] and blood sugar levels will ultimately help many people in poverty be                
able to take care of family members and also communicate to health experts more easily. 
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Chapter 2: System Level 
 
2.1 System Level Overview  
 
Figure 2-1: System Level Overview 
 
2.2 System Level Requirements 
In order to make a well-rounded product, there were various concerns that needed to be 
addressed in the creation of our device.  
 
Table 2-1: Economic, Ethical, and Ergonomic Considerations  
Consideration Reasoning Device Requirement 
Commercial 
Cost 
Device should be 
affordable so that 
communities are able 
to buy it in developing 
countries, specifically 
India.  
- Maximized efficiency of components  
  - Total cost of device should  not exceed $200 
Ethical 
Concern for 
Device not to 
Harm Patient 
Use of the medical 
device should not 
cause negative side 
effects or hurt patient 
- Add in acrylic plastic between LED and skin to 
eliminate skin-electronics contact.  
- LED wires of device are insulated so that patient 
does not touch them.  
Manufacturing 
Consideration 
The materials should 
be environmentally 
sound and affordable.  
- Material chosen should be affordable, non-toxic, 
and recyclable to eliminate waste.  
- Device should be able to be intuitively put 
together to optimize manufacturing process.  
 
15 
 
2.3 Benchmarking Results: ​The major goals of our project was to create a device that is simple                 
to use and affordable for the communities where aim to introduce our device. At the same time                 
the device needs to as accurate as most commercial individual sensor alternatives in the market,               
to ensure it meets the standards of safety. Taking into consideration the necessity for our device                
to be connected to a cell phone to transmit the data, another goal was to ensure that the device                   
can connect to most mobile devices in the market, however, due to the capabilities of a                
smartphone over a regular mobile device we aimed to prioritize the smartphone compatibility of              
our device due to time constraints.  
 
Accuracy: ​Because of the importance of taking the vital signs correctly, accuracy is one of the                
major requirements in our device. The way we went about ensuring we obtained our desired               
accuracy for each of our sensors is that we bought a market alternative for each sensor to have                  
something to compare our measurement data to. Each market alternative was chosen based on              
price range and reliability of the device based on professional reviews. Our goal then was to                
ensure that each of our sensor measurements was within a 5% error margin of the measurements                
from the market alternative. 
 
Price: ​In terms of price, something to consider is that our device needed to be as affordable as                  
possible from the perspective of the community we want to introduce it to. India only spends                
around 4% of it’s GDP in healthcare, around half of the average percentage spent by most                
countries [1]. Therefore most patients have to pay from pocket to be able to see a doctor and                  
paying for private healthcare is really expensive. Taking this into consideration our goal was to               
make our device cost to be between $100-$150 which is roughly the price of a cell phone in                  
India (7000-1500 rupees is the range of prices for low to high end cell phones) ​[18]​. With the                  
idea that mass manufacture of our device would drive the price even further down and that our                 
business plan is centered around the idea of a whole community using our device, we saw this                 
range of prices as quite affordable for a community.  
 
Portability: ​One of our aims was to make the device as small and light as possible so that it can                    
be carried by any adult or teen in a moderate size backpack or bag. The encasing for the device                   
previously developed was about 8x6x4 inches, the reason for this size has mostly to do with the                 
size of the breadboards used for the controller. For our controller we aimed to use a PCB board                  
which would be a lot smaller and therefore not need as much space. Overall our project should                 
be easy to carry and fit in any moderate size backpack or purse.  
 
Simplicity: ​The communities that we are aiming introduce our device to might not have any               
knowledge of how to use each sensor separately. One possible solution we looked into              
developing, is to possibly add a manual or a set of instructions on how to use our device. Taking                   
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into consideration the business plan for our device, this set of instructions would be for an                
individual that together with a bit of training should be capable of using the device. Because of                 
the language differences, we would need to rely on images or very short phrases that will give                 
some background information on how to use the device. While each sensor is not hard to use if                  
having some knowledge of how it works, a manual would ensure the patient has some               
understanding of how to use it. Since we our aim was to make each sensor in our device very                   
similar to their more well known market alternatives, a medical professional should be able to               
use it quite comfortably. 
 
Mobile Phone Penetration: Our decision to use a cell phone for wireless communication as              
opposed to a PC is that we took into consideration the mobile phone penetration rate vs PC                 
penetration of the region. While PC penetration is only at 9% in India, meaning 9% of the                 
population has access to a PC or knows how to use one, the mobile market is at an impressive                   
%80 in comparison[18]. Furthermore, India is now considered the second largest mobile market             
in the world, with an estimated 900 million mobile connections.  
 
Smartphone Compatibility: It is important to take into consideration the difference between            
any mobile device and smartphones. While around 80% of the population in India owns some               
form of mobile device, only 30% of those devices are smartphones[18]. This percentage is              
expected to increase, however, and as it currently stands it forced us to consider whether our                
device needed to be developed for a smartphone device or for any mobile device. A smartphone                
device would be certainly easier to use since there are already many apps that have similar                
functions to what we need to create. However, if we made our device capable of transmitting the                 
information through a non-smartphone device it would follow that it could be easily used by a                
smartphone device and therefore our device would be easier to integrate and use in any               
community. Taking into consideration this information, our goal was to formulate a plan to              
connect our device with any mobile device, if this proved to be too difficult then we would move                  
towards using a smartphone as the means of communication for our device. 
 
2.4 Functional Analysis 
 
Table 2-2: General and Specific Functions of Each Device Component 
Subsystem (Top down) Function 
Overall Prototype  
(PCB + Ear Sensor + Blood Pressure Sensor) 
This system works together in conjunction 
with a computer to be able to send the data 
from the sensor to Arduino to Matlab for 
processing.  
PCB & Arduino Uno The PCB is the heart of the device, where all 
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the electrical circuits needed for the sensors 
are located.  
Ear Sensor, Blood Pressure Sensor, Glucose 
Sensor 
The ear sensor is composed of three LEDs 
and two photodiodes. It is housed in an ABS 
3D printed ear clamp. The glucose sensor is 
also housed in the ear clamp.  
 
Blood pressure sensor is connected on one 
end to the PCB and to the cuff/pump on the 
other end.  
 
2.5 Team and Project Management 
This project required thorough organization, communication amongst team members and          
with our advisors throughout the whole school year. We kept organized by taking notes during               
meetings and keeping a gantt chart to stay on top of deadlines [refer to Appendix E]. A challenge                  
that was encountered at some points throughout the project was working to build an affordable               
device that also could provide accurate results. The budget for this project was $668. The               
glucose sensor was the most experimental for the vital sign kit, and resultingly, the electrical               
components were very expensive. We dealt with this challenge by only buying what we were               
able to with our funding options and buying more components if all others were non-functional.               
In addition, having a small budget to ensure the device stayed at a low overall cost taught us to                   
thoroughly research the properties of the electrical components used so that we have optimal use               
of our device.  
Furthermore, the design process continued to evolve throughout the school year. The            
main sections that were needed at the beginning were the electrical circuits for the blood               
pressure, pulse oximeter and glucose sensor. Then, the ear clamp housing was designed to put               
the device together. As we tested our device with several patients, we noted how we can improve                 
the ear sensor and PCB housing to make the product more compact and easy to use.  
 
2.6 Risks 
This project did not pose a risk to any people that use the product. In order to use the                   
medical device on other patients, we had to be approved by the Santa Clara Institutional Review                
Board. This involved an extensive application with details on why, how, and what we intended to                
test. We did trainings and also require consent forms for patients to sign before they could be                 
tested. For testing people’s heart rate, we do require that the person do a form of moderate                 
exercise for 30 seconds to get the heart rate elevated. If for some reason the patient suffered an                  
injury for this part of testing, that would be our major concern. There is no danger in being tested                   
for blood sugar, glucose and oxygen saturation because it is all non-invasive.  
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Chapter 3: Subsystems Level 
 
3.1 Blood Pressure Sensor 
 
3.1.1 Role/Requirements  
The blood pressure sensor functions based on the fluid pressure found in the patient’s arterial               
walls. There are two points of interest to be monitored as the patient’s heart beats: When the                 
patient’s heart is contracted a high pressure is to be monitored, which is known as the systolic                 
pressure, and when the patient’s heart is relaxed, the lower pressure, known as diastolic pressure               
can be measured. The blood flowing through an artery between these systolic and diastolic              
pressures causes vibrations in the arterial wall that can then be detected and measured through               
voltage signals[14]. 
 
3.1.2 Options and Trades 
Since this project was an adaptation of the previous year’s prototype, we decided to work with                
the current blood pressure cuff and pressure transducer to reduce the price of purchasing new               
components. These components functioned well on their own and their accuracy outweighed the             
cost of purchasing new components [See Appendix F for components].  
 
3.1.3 Design Description 
The initial approach was to reconstruct the blood pressure circuit from breadboard design that it               
was previously implemented on. This included recreating the blood pressure circuit on a             
breadboard to begin with, as the previous team did not leave proper schematics for our referral.                
The main blood pressure schematic that became our reference is shown below in ​Figure 3-1. This                
was taken from Freescale’s articles on design of medical devices [17]. [See Appendix D for               
ExpressPCB designs] 
 
 
Figure 3-1: Freescale Blood Pressure Circuit Design 
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As we referred to this ideal schematic, our breadboard design began to come together with our 
various components. The approved circuit design at our first stage of testing is shown below in 
Figure 3-2.  
 
Figure 3-2: Breadboard Blood Pressure Circuit Design 
 
3.1.4 Supported Analysis 
The overall process of blood pressure testing began once the circuit implementation was             
completed. The design was finalized into the PCB schematic implementation and final testing             
began once our overall PCB was constructed. Results from both our group and various test               
subjects can be seen in Appendix C.  
 
3.1.5 Test Procedures 
The testing procedures for the blood pressure followed the testing procedure that would be              
encompassed in all of our sensors. Our patient would first take their blood pressure from our                
commercialized blood pressure sensor, so that we would have a baseline to compare their results               
against our prototype. Once this was done, our patient would use our blood pressure cuff so that                 
we could measure our own data through our device. As a group member would manually pump                
the blood pressure pump, corresponding data would appear through our Arduino code. An             
example plot is shown below in Figure 5. 
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Figure 3-3: Arduino Plotted BP Results 
 
The above plot would then correspond to data points that would be measured through Excel.               
These data points would then be converted into a plot to be analyzed to find the patient’s                 
corresponding systolic and diastolic values. An example to this data is shown in Appendix A. 
 
The bumps on the right half of the plot correspond to the patient’s heart rate and this data can                   
also be measured through the blood pressure analysis. 
 
3.2 Glucose Sensor 
  
3.2.1 Role/Requirements 
This subsystem is the non-invasive blood glucose sensor. It functions to measure the blood              
glucose concentrations of a patient. The requirements for this sensor are as follows: 
● Non-invasive (no blood draw, no damage to patient tissue) 
● Accurate measurements (as measured on glucose standard solutions) 
● Small in size (to fit in the ear sensor with the pulse oximeter) 
  
3.2.2 Options and Trades 
Options for the development of this sensor were very limited. Due to the experimental nature of                
this technology, there are very few companies that sell the components that could be used to fit                 
the determined design for this device. The reason for choosing the wavelength of LED that we                
did is due to the maximized glucose interactions, and minimized water interactions while still              
maintaining a feasible path length (see figure 3-7). The photodiode was selected based on its               
ability to absorb the desired wavelength (see Figure I-2, in Appendix I), its cost, and its size.                 
Since the purpose of the device as a whole is to be portable and inexpensive, the size would need                   
to be minimal and its price be as low as possible as well. 
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3.2.3 Design Description 
The glucose sensor is composed of a single near-infrared (NIR) LED that emits a wavelength of                
1550 nm, and a light receiver, in this case being a photodiode that receives the 1550nm                
wavelength. These two components are positioned within the ear sensor, with the NIR LED              
positioned on the same side as the pulse oximeter LEDs, and the photodiode positioned on the                
same side as the pulse oximetry photodiode, with them positioned directly across from each              
other. 
 
Figure 3-4: 1550nm LED 
 
 
Figures 3-5: Glucose Photodiode [21] 
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Figure 3-6: Glucose LED and photodiode in place in ear sensor housing 
 
The novelty of this approach is the non-invasive nature. While normal sensors require exposure              
and direct testing of patient blood, the spectroscopic nature of the NIR LED-photodiode method              
removes the need for any tissue damage, or need for direct exposure to body fluids. Instead, the                 
1550 nm wavelength is able to pass through the tissue of the patient with minimal interactions                
with the water (see figure 3-7) and tissue components [9] of the patient, and maximal interactions                
with the glucose dissolved in the blood, while maintaining a path length great enough to travel                
through the entire tissue, in this case being the ear lobe. This method reduces sanitation concerns,                
reusability concerns, as well as general safety and health concerns for the patient associated with               
the testing process relative to commercially available methods. 
 
 
Figure 3-7: Absorbance spectra of glucose vs. water [22] 
 
Glucose molecules reflect light at a wavelength of 1550 nm, indicating that as the glucose               
concentration increases, the amount of light received by the photodiode on the other side of the                
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tissue or glucose solution is reduced, as more of the NIR photons are reflected back towards the                 
LED instead of passing all the way through the tissue or solution. 
  
3.2.4 Supporting Analysis and Test Procedures 
The glucose sensor was tested by using several glucose solutions in water of a predetermined               
concentrations to obtain raw voltage readings from the device, and then correlating each of those               
glucose solutions to their respective glucose solutions to produce a standard curve. This standard              
curve would then be used to correlate voltage readings from patients to the appropriate blood               
glucose levels. The glucose solutions used were in units of milligrams per deciliter: 30, 50, 70,                
80, 90, 100, 125, 150, 200, 2000. These particular concentrations were selected for their              
physiological relevance; 70-100 mg/dL is generally considered to be a healthy blood glucose             
concentration before eating a meal, and 30 and 50 mg/dL are both considered very low blood                
glucose concentrations (hypoglycemia). 125, 150, and 200 mg/dL are all considered to be high              
blood sugar (hyperglycemia). 2000 mg/dL was a concentration selected in order to ensure the              
sensor was responsive, and to help detect the linearity of the standard curve. 
  
 
Figure 3-8: Glucose solutions in glass bottles. Arranged left to right; 30, 50, 70, 80, 90, 100, 125, 
150, 200 mg/dL 
 
The glucose solution was put into a small container composed of black acrylonitrile butadiene              
styrene (ABS) plastic and transparent acrylic plastic. This container was a small box in which the                
glucose solution was put in to provide a fixed path length (5mm) for the glucose LED and                 
photodiodes to be placed against. Each glucose solution was put into the black box for               
measurement by the glucose sensor to form the standard curve. 
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Figure 3-9: Black glucose solution testing box in testing 
 
The standard curve produced by our device did not provide data to support a linear correlation                
between the glucose concentration and the voltage output of the glucose sensor, following             
several attempts throughout the academic year. One of the last trials did produce a correlation,               
but following trials were not able to replicate those results. 
  
 
Figure 3-10: Trial 1 of Glucose sensor 
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Figure 3-11: Trial 5 of Glucose sensor 
 
The expected results based on literature research is that with the increasing glucose             
concentrations, the voltage output by the glucose photodiode would be reduced, as the             
transmission of light is reduced with the greater number of glucose molecules blocking the path               
of the 1550 nm photons. However, the data retrieved by the glucose sensor demonstrate a               
seemingly random voltage output for each glucose concentration, instead of the expected            
negative correlation. 
 
3.2.5 Verification 
Due to the nature of the glucose sensor we produced, it is non-invasive; it does not require direct                  
access to blood or damage to body tissues for measurement to occur, thereby meeting the               
requirement of being non-invasive. However, following the various tests performed on the            
sensor, no accurate replicable standard curve was obtained, thereby indicating a lack of accurate              
glucose measurements. The size of the sensor, on the other hand, was appropriately sized, and               
was able to fit into the ear sensor, eliminating the need to make a separate housing/sensor for the                  
glucose sensor to be an independent component. 
 
3.3 Pulse Oximeter  
 
3.3.1 Roles and Requirements 
The device is intended to be compact, simple, and accurate.  
Requirements:  
● Ear lobe is designated path for oxygen saturation measurement because of less            
light reflection and diffraction (no bones or thick tissue for light to penetrate).  
● Non-invasiveness is required to limit harm to patient and improve ease of use.  
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● Affordability of pulse oximeter components allows for overall price of device to            
stay low. 
 
3.3.2 Options and Trades 
When considering how to design this sensor, we could have chosen the finger or the ear.                
However, since we wanted to have multiple sensors on one clamp, we chose to design our device                 
based on the decision of testing through the earlobe. There was no ambiguity in the types of                 
LEDs that we could have used because literature has shown that 650 nm and 940 nm                
wavelengths will yield the best results in calculating oxygen saturation levels. For the chosen              
photodiode, there were multiple options in the market, but the one that was chosen was based on                 
what the previous year’s team did. This photodiode worked well in the preliminary testing and               
was kept for final testing.  
 
A pulse oximeter measures the oxygen saturation in the blood stream. Oxygen is necessary for               
the body’s survival, and so it is an important sign to keep track of. Hemoglobin is a molecule that                   
transports oxygen molecules to the desired locations. The way this is done with our device is one                 
of the most common methods of detection, light spectroscopy.  
 
 
Figure 3-12: Two-LED pulse oximeter setup. Two LEDs and a photodiode (receiver of light) to               
detect oxygenated and deoxygenated blood cells. [23] 
 
There are two LEDs that are used to measure the oxygenated hemoglobin and deoxygenated              
hemoglobin in the blood stream. Commercial devices often test oxygen saturation through the             
finger, but our device tests through the ear. This should have no impact on the oxygen saturation                 
measurement. The ear was chosen to be tested because there are no bones in the earlobe and this                  
limits light scattering. Two LEDs, at wavelength 650 nm and 940 nm were chosen because               
literature shows that red light is most absorbed by deoxyhemoglobin and least absorbed by              
oxyhemoglobin, while at 940 nm, oxyhemoglobin has the highest absorption and           
deoxyhemoglobin has the least absorption.  
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Figure 3-13: Oxyhemoglobin vs. deoxyhemoglobin absorption spectra [23]. This image shows           
the maximal absorption of oxyhemoglobin and deoxyhemoglobin at different path lengths. 650            
nm (red light) and 950 nm (infrared light) LEDs were chosen because of their optimal results.                
Data is taken with each LED in which the arterial blood flow is measured. The relationship                
between the absorbance of oxy- and deoxy-hemoglobin is quantified to calculate the oxygen             
saturation. The data is taken from the LED readings and then uploaded to Matlab for further                
processing. [Refer to Appendix A for Matlab code].  
 
 
Figure 3-14: Pulse oximeter equation. This equation calculates the oxygen saturation by taking             
the log of the number of peaks (AC component only) for the red LED divided by the log of the                    
number of peaks (AC component) of the infrared LED. This ratio is multiplied by 100 to get the                  
final oxygen saturation percentage.  
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3.3.3 Design Description 
 
 
Figure 3-15: Pulse oximeter components. The main components needed for the pulse oximeter             
are shown above: 650nm LED (top left), 940nm LED (top right), OPT101 Texas Instruments              
photodiode (bottom).  
 
The circuit design for the pulse oximeter was based on Freescale’s articles on medical devices               
[16]. The circuit design is shown in Figure 3.16 below. [See Appendix D for ExpressPCB circuit                
design]. 
 
 
Figure 3-16: Freescale Pulse Oximeter Circuit Design 
 
Initially out testing of the circuit design was done on a breadboard and then the circuit design                 
was implemented in a 4 layer PCB. Please refer to Appendix C & D for details on circuit design                   
and implementation.  
 
3.3.4 Supported Analysis and Testing Procedures 
The pulse oximeter testing was conducted in two states, with a resting and elevated heart rate.                
Testing oxygen saturation and heart rate both when a patient is at rest and then after doing                 
moderate exercises further broadens the ability of the sensor to be able to accurately detect               
oxygen saturation and heart rate. 
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Figure 3-17: Initial pulse oximeter testing setup. Red shining LED with photodiode across it 
(also shining in red). Finger was placed in gap between LED and photodiode. 
 
Initially, testing oxygen saturation with the device prototyped on the breadboard was difficult             
because there was not a set path length and the finger was put between an LED and photodiode                  
to see if the arterial blood flow could be detected. The finger was initially tested because the ear                  
clamp SolidWorks design had not yet been created. Arduino serial plotter was used to get               
real-time results of arterial blood flow when finger was placed between LED and photodiode.  
 
 
Figure 3-18: Finalized pulse oximeter testing setup. The finalized testing setup with fixed path              
length between LEDs (red LED is shining) and photodiode.  
The final testing setup was used with the ear clamp to house the LEDs from outside light as best                   
as possible, and the photodiode on the other half of the ear clamp. In addition, the LED’s were                  
directly connected to the PCB (no longer designed on a breadboard).  
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Table 3-1: Pulse oximeter and heart rate data from trial 1.  
   
 
Oxygen saturation and heart rate were tested six different times, where the average error of both                
the heart rate and oxygen saturation are under ten percent compared to commercial products.              
There are promising results from this sensor; the next step is to test the pulse oximeter accuracy                 
when the patient has an elevated heart rate.  
 
Table 3-2: Pulse oximeter and heart rate data from trial 2.  
Percent Difference Patient 0 
HR: Resting 35% 
  Elevated 11% 
Percent Difference Patient 1 
HR: Resting 6% 
  Elevated n/a 
Percent Difference Patient 2 
HR: Resting 1% 
  Elevated 2% 
Note: The heart rate was calculated in MATLAB from the LED raw data [Refer to Appendix A 
for further detail].  
 
There is an outlier in this data set where Patient 0 has a resting heart rate difference of 35%. This                    
is the only point where this has occurred, and it is hypothesized that the error is because of the                   
sensitivity of the commercial sensor. However, the average error for the elevated heart rate is               
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6.5% for two out of the three patients. Patient 1’s elevated heart rate could not be calculated                 
because one of the data sets did not save correctly and could not be processed.  
 
3.4 Microcontroller 
 
3.4.1 Role/Requirements  
An essential component in our device is a microcontroller that is able to take in the analog                 
signals of each of our sensors and transform the signal into a digital signal. The digital signal is                  
then is then analyzed by the software of the device connected into the microcontroller and turn                
into the calculations of the measurements of the patient’s vital signs. At the same time there are                 
filters, amplifiers and buffers that need to be implemented to clean the incoming signal from               
each of our sensors.  
 
3.4.2 Options and Trades 
Taking the requirements into consideration we decided on a set of possible implementations for 
our microcontroller and the implementation of our circuit designs: 
 
● Breadboard and Arduino Uno: What the previous team did was to implement all of the               
circuit designs into a breadboard and connect this breadboard to the sensors and to an               
Arduino Uno Microcontroller. This method of implementation had a number of issues            
since the breadboard components could fall off and had a greater error margin in treating               
the signals. At the same time, while the Arduino Uno is an excellent microcontroller that               
could supply all the needs of the project, it is also a component that is relative expensive                 
to the overall project.  
○ Pros 
■ Easy to Implement 
■ Easy to modify 
■ Inexpensive implementation of circuit designs 
○ Cons 
■ Expensive microcontroller 
■ Wide error margin with measurements 
■ Convoluted wiring and loose parts in implementation of circuit design 
● PCB: Taking into consideration what the previous team did, we decided that the best              
solution was to design and order a PCB that included all of our circuit designs, as well as                  
the required components to implement a simpler microcontroller. By implementing a           
simpler microcontroller we would be cutting down on the cost of using an Arduino Uno               
microcontroller. The component that we would be using would be the Arduino Uno chip              
that would require coding to ensure it works as we need it. A PCB with surface mount                 
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components would give us better accuracy due to the smaller margin of error of the               
surface mount components and a more sturdy implementation of our circuit designs.  
○ Pros 
■ Inexpensive compared to alternatives 
■ Smaller margin of error with surface mount components 
■ Study implementation of circuit designs 
○ Cons 
■ Harder to modify 
■ Harder to implement due the necessity to code 
● PCB and Arduino Uno: For the implementation of our project we made some             
adjustments were we decided to implement all of our circuit designs into a PCB shield for                
the Arduino Uno. Essentially we created a PCB that can be connected to the Arduino               
Uno, the reason for such a modification is that due to time constraints we would not be                 
able to fully implement the microcontroller into our PCB. At the same time we added a                
section in our PCB that allowed us to modify our circuit design for our Glucose Sensor                
which did not work as expected. (​See Appendix D for PCB Layout). 
○ Pros 
■ Smaller margin of error with surface mount components 
■ Study implementation of circuit designs 
■ Capable of modification 
■ Easier to implement 
○ Cons 
■ More expensive overall due to the need for a microcontroller 
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Chapter 4: System Integration, Tests, and Results 
 
4.1 PCB 
In the beginning, it was imperative that our requirements would include improving overall             
accuracy of the device as compared to last year while reducing the price as well. The major                 
decision was then made to implement our own PCB design. Including this PCB would make the                
following improvements: 
● Increase accuracy 
● Reduce Size 
● Refine usability 
As a result of this decision, the overarching system to be integrated and tested first was the PCB.                  
Since the PCB would allow for the capability of all of our sensors to function efficiently, it was                  
vital that this would be the initial system to be integrated into our prototype. The finalization of                 
our PCB came along in the following steps: 
● Recreation of circuit for each sensor on a breadboard 
● Additional and various filtering 
● Overall PCB design and schematic finalization 
● Printing of board and soldering of components 
The final PCB design is shown in Figure 4-1 below, which integrates each sensor and its various                 
components and attachments. 
 
Figure 4-1: Final PCB Design with External Components 
 
 
 
34 
4.2 Breadboard Iterations 
There were three main circuits implemented on each breadboard: the Blood Pressure circuit             
[Figure D-1], Pulse Oximetry circuit [Figure D-2], and the Glucose circuit [Figure D-3]. The              
various schematics were implemented onto three separate breadboards, that allowed for simple            
modification [Appendix C]. A lot of our initial predictions were obtained from the simple              
calculations we performed prior to our schematic design. Blood Pressure testing was deemed             
correct when we were able to fully measure patient’s data from the breadboard and the same was                 
done for the Pulse Oximeter. Testing for the Glucose sensor required much more custom              
iterations. Once our breadboard implementations were cleared they were implemented on the            
PCB to conduct further testing. 
 
4.3 Blood Pressure 
Blood Pressure testing began by utilizing our PCB design [Figure D-1 Appendix D] . Through               
our testing, our accuracy with the systolic and diastolic pressures compared against the             
commercial device were found to be within 3-7%, which correlates to our requirement of              
improving the accuracy of this sensor as compared to last year. Various results through our               
volunteers are recorded in [Table C-1]. 
 
4.4 Pulse Oximeter 
Pulse Oximetry testing is shown in [Table 3-1 and 3-2]. Our breadboard testing was done by                
taking data being measured through the patient’s finger, as opposed to the earlobe sensor that               
would later be implemented. Our main contribution to enhancing the accuracy of this sensor was               
the inclusion of the aforementioned earlobe sensor. Below in Figure 4-2 is the housing that we                
created for the earlobe sensor to house the LEDs and photodiode. 
 
 
Figure 4-2: Ear clamp Sensor 
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We then measured patient data through this process. The heart rate recorded as compared against 
our commercial product was found to be within 8% accuracy, and our blood oxygen saturation 
levels all fell within 1% accuracy [Table 3-1 and 3-2]. 
  
4.5 Glucose 
Glucose was the most difficult sensor to implement, and the testing required constant variation              
throughout the year. Testing was done through measuring the difference between various            
concentrations of pure glucose in a water solution. As shown in Figure 3-8, we began with                
having these solutions in a latex balloon, which would allow for more light to go through so that                  
we could gain a more realistic measurement to that of the skin. As time went on, we decided to                   
design an opaque container with a clear opening to allow for the glucose to be seen. This                 
approach is shown below in Figure 4-3. 
 
 
Figure 4-3: Opaque Glucose Container 
 
This slightly increased the correlation of data read to that of the various solutions, but our group                 
decided to move forward and begin testing with our PCB design. We created a test pad on the                  
right half of the PCB to allow for alterations [Figure D-6]. 
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Chapter 5: Cost Analysis 
 
Table 5-1: Overall Cost of Project 
Component Number 
of Items 
Price per 
Unit 
Total 
Cost 
*Order 
Cost 
Commercial Pulse Oximeter 
Santamedical SM-240 OLED Finger 
Pulse Oximeter 
1 $54.95 $54.95  
Commercial Blood Pressure Monitor 
Omron 7 Series Upper Arm BP Monitor 
1 $64.99 $64.99  
Commercial Glucose Monitor 
One Touch Ultra Diabetes Testing Kit - 
One Touch Ultra Meter, 
100GenUltimate Test Strips, 100 30g 
Lancets, 1 Lancing Device and 100 
Alcohol Prep Pads 
1 $40.95 $40.95  
Commercial Thermometer 
Beyoung Axillary Thermometer 
1 $6.99 $6.99 $178.03 
Custom 4-layer circuit board from 
ExpressPCB.com ( PCB boards) 
3 $25.00 $75.00 $110.93 
5mm Red LED ​(660nm) 10 $0.29 $2.90 
 
$10.20 
5mm IR LED ​(940nm)  10 $0.68 $6.80 $21.06 
Glucose Meter LED 
LED1550E - Clear Epoxy, 1550 nm, 
2mW 
8 $17.95 $143.60 $197.41 
GPD Optoelectronics GAP 136 in GaAs 
Photodiode ​(900-1650nm) 
5 $20.00 $100.00 $191.78 
TI OPT101P Photodiode ​(400-1100nm) 2 $7.46 $14.92 $26.71 
Honeywell ASDX015PDAA5  ​Pressure 
Transducer 
1 $11.69 $11.69 $20.43 
Hand Pump:  ​Omron Digital Blood 
Pressure Parts & Accessories 
1 $14.95 $14.95 $14.95 
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Pressure Cuff: ​`ComFit Cuff 9" ​ 17" for 
HEM773AC & HEM780 
1 $18.95 $18.95  
2nd Hand Pump:​ Santamedical Adult 
Deluxe Aneroid Sphygmomanometer 
1 $13.95 $13.95  
2nd Commercial Pulse Oximeter: 
Santamedical Generation 2 OLED 
Fingertip Pulse Oximeter 
1 $18.95 $18.95 $52.98 
Condoms (for testing):​Trojan ENZ 
Non​Lubricated Condoms, 12 Count 
1 $5.97 $5.97 $10.81 
MATLAB and Simulink Student Suite 1 $99.00 $99.00 $99.00 
Chip Components: Resistors, Capacitors, 
Inductors, etc. (DigitKey.com)  
See Table 
of 
Compone
nts 
$23.53 $23.53 $40.33 
Arduino Mega Microcontroller 1 $40 $40 $40 
Total cost:  $758.03 $1014.62 
*Including shipping and cost 
 
 
Table 5-2: Cost of Device 
Item Cost 
Blood Pressure 
● 3Way Dump Valve  
● Handpump & Pressure Cuff 
● ASDX015PDAA5  Transducer 
Total = $ 47.53 
$2 
$14.95 + $18.89 = $33.84 
$11.69 
Glucose 
● LED1550E 
● GAP 136 Photodiode 
● Spring for Ear Clamp 
Total = $ 38.95 
$17.95 
$20 
$1 
Oximeter 
● TI OPT101P Photodiode 
● 5mm Red LED (660nm) 
● 5mm IR LED (940nm)  
Total = $ 8.43 
$7.46 
$0.29 
$0.68 
PCB $25 
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Arduino Uno $40 
Surface Mount Component (Res, Caps) $4.49 
Surface Mount Components (Op-Amps, 
Mosfets) 
$8.13 
Acrylonitrile-Butadiene-Styrene (ABS) Free* 
Total Cost $133.58 or $172.53 (Glucose) 
* Donated by the Frugal Lab 
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Chapter 6: Patent Search and Business Plan 
 
Table 6-1: Patent Search 
Patent ID Patent Title Description 
US 8676284 B2 
Method for non-invasive blood 
glucose monitoring 
Using metabolic heat 
measurements to measure blood 
glucose levels 
US 20150112170 A1 
Device and method for 
non-invasive glucose monitoring 
Transmission of terahertz waves 
through a tissue to be received 
by a sensor on the opposite side 
US 8135450 B2 
Noninvasive glucose sensing 
methods and systems 
Using electromagnetic waves or 
ultrasound waves, dependent on 
tissue thickness, length, width, 
diameter, etc. 
US 6556852 B1 
Earpiece with sensors to 
measure/monitor multiple 
physiological variables 
Pulse oximeter ear sensor 
positioned against rear wall of 
the ear canal 
US 8588880 B2 Ear sensor 
Optical assembly sensors used at 
concha of the ear 
US 5931791 A 
Medical patient vital 
signs-monitoring apparatus 
Portable ultra-lightweight 
multisensor including ECG, 
pulse oximetry, and blood 
pressure 
US 8235897 B2 
Device for non-invasively 
measuring glucose 
Ear clamp noninvasive blood 
glucose sensor using ultrasonic, 
electromagnetic, and thermal 
methods 
 
Business Plan 
The team had initially designed our device to be sold for individual purchase in India to a certain                  
amount of people in a community. We were able to get into contact with NOORA Health [19],                 
who suggested that our business model could function as follows: Patients would only be              
charged per test rather than purchasing an entire model of our device. Implementation would              
then require that our components would be assembled in India, which would also reduce the               
overall cost of our device. Since our device was intended to be financially responsible, this               
business model functions well for our requirement. 
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Chapter 7: Professional Issues and Constraints 
  
7.1 Ethical: 
A number of ethical questions needed to be raised with the development of this device. The first                 
question is about the access to a device like this; while it is significantly less expensive than                 
currently commercially available multi-sensors, it is still relatively expensive for low-income           
families. As such, there is a question of whether this device contributes to the problem of access                 
to health care. While this device wouldn’t be that inexpensive, it is the sort of thing that multiple                  
users can pool money together to buy, as there is little concern for sanitation issues with respect                 
to this device. 
  
Another concern to be considered is that since this device is designed to be used with mobile                 
devices, this doesn’t increase the access to health information for those in greatest need for               
increased access. Areas in the world that do not have cell phone towers in place, or in areas                  
where most people are too poor to afford luxuries such as mobile devices, this device serves very                 
little purpose. While it does address a large population of people that could use the help of this                  
device, it does very little to aid the most vulnerable people in communities around the world. 
  
One last concern is with increased access to health information such as this, there is also an                 
increased need for professionals who can help users interpret the data they are receiving from the                
device. Similarly to getting one’s genome sequenced without the consultation of a doctor or              
genetic counselor, such data can mean very little, or even cause users to form false               
opinions/diagnoses of themselves, as they may not seek out the appropriate individuals that can              
help users make decisions with the data they measure themselves. 
  
7.2 Health and Safety: 
Given that products such as the one produced as a result of this project are made for use by the                    
general public, there is a need to ensure that the product meets certain safety standards. 
  
In general, a product should be safe enough that an adult can use the product for normal                 
functions without any risk of damage to their body, those around them, or any property around                
them. This implicates things such as making sure it doesn’t produce too much heat, that there are                 
no exposed wires that could potentially shock the user, and that the light intensity produced by                
the LEDs is low enough that no damage would come to the user for looking into it for a moment.                    
However, the assumption that there will be those who will use the device for purposes other than                 
that which it was made for, and a reasonable amount of precautions should be taken to prevent                 
harm in those functions too. This includes ensuring that there aren’t any small parts that can                
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easily come off and be swallowed by infants or animals, as well as that there are no fire hazards                   
associated with the product. 
  
For the sensors that involved the use of LEDs, all were checked by Santa Clara University’s                
Safety staff to ensure that there is no concern associated with looking into the LEDs directly, and                 
that there would be no direct contact with any parts that have potential to heat up. 
  
The question does come up, to what extent does one increase the cost of a product to cover for                   
safety concerns that fall outside of normal use. This becomes a problem, largely because almost               
anything can be used incorrectly to cause harm to a person, so a product could never be                 
completely safe, so a line must be drawn to ensure that and reasonably possible concerns are                
covered, such as burns, sharp edges or corners, damage to eyes, or electrical shocks. 
  
7.3 Environmental Impact: 
The primary environmental impacts as pertain to this device are the proper disposal of the               
components used to make the device. On a per-use basis, this device produces no waste               
whatsoever. Additionally, this device has an approximate minimum life expectancy of five years             
based on the lifespan of the more fragile components. However, once the device is no longer                
functional, there are a number of components that need to be disposed of properly. This includes                
a number of plastics and rubbers that are used to make the housing and tubing for the device, as                   
well as wiring and various small electrical components (LEDs, photodiodes, capacitors, resistors,            
etc.). 
  
The production of the photodiode for the glucose sensor has an indium-gallium-arsenide alloy.             
Producing this alloy involves the use of a highly toxic gas [20], which is an environmental                
concern. However, once this gas is deposited onto a substrate, it is inert. 
  
7.4 Science, Technology, and Society: 
This product is targeted to communities in developing countries that are far away from hospitals               
and clinics, but has implications even in developed countries where people are far away from               
hospitals and clinics, but still have access to mobile devices. The development and             
implementation of this device has the potential to provide communities with a greater degree of               
health independence by giving users access to their vital sign information in their towns or               
homes, help them save time and money by reducing the frequency of unnecessary doctor’s              
appointments, and has the potential to reduce costs even of emergency medicine companies that              
commonly use multi-sensors. 
  
There are some potential negative consequences in these communities as well. Giving people             
greater access to these tools does give people greater opportunities to learn to track their own                
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vitals, but also leaves potential for people to do so incorrectly, and potentially key details that                
result in spending money on going to see a doctor when not necessary, or avoiding the hospital                 
when a visit is necessary. Additionally, with an implemented telemedicine component, unless            
encryption of the medical information is very well developed, there is potential for users’ health               
information to be stolen through the use of mobile devices, which poses a serious risk to users, as                  
this data can be sold to health insurance companies. 
  
7.5 Civic Engagement: 
A medical device such as the device produced in this project would require FDA approval before                
the device could be sold commercially here in the United States, and would have to go through                 
similar health regulation agencies in whatever country this product is to implemented in. This is               
particularly true with respect to the glucose sensor portion, as the rest of the sensors are simply                 
cheaper/adapted forms of technologies that are already FDA approved. The glucose sensor            
technology being used for the glucose sensor in this device is not yet approved by the FDA; there                  
are a number of companies that are in the FDA approval process at the time of this writing that                   
use a similar technology. This means that in the next few years as these technologies are                
approved, it will be easier to push this device through as similar technologies have been               
approved; the primary difference of this device is the reduced cost and simplicity. Additionally,              
testing on a greater number of subjects before trying to get FDA approval would increase the                
chances of receiving the approval, as data demonstrating the efficacy of the technology of this               
device would be helpful, as well as tests on the safety of the glucose sensor technology as a                  
potential danger would be necessary for approval. 
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Chapter 8: Summary and Conclusions  
 
8.1 Conclusions 
The objective of this project was to develop an affordable kit equipped with sensors that will be                 
used to take a patient’s vital signs, such as blood pressure, heart rate, blood glucose               
concentration, and blood oxygen saturation. This kit is intended for developing countries such as              
India in order to help alleviate the health care issues of people not being able to check on how                   
their overall health is doing. This device, in the future, could detect if a person would need to                  
make the arduous trip to go to the doctor. Our vital sign kit is compact and also easy to use. We                     
found that on average, the pulse oximeter and heart rate sensor had less than 10% error compared                 
to commercial products. The blood pressure sensor average is in the range between 10% -20%               
compared to the commercial sensor, however, we know that our current limitation that is              
preventing us from reaching less than 10% error is the Matlab code that processes the data. In the                  
future, that can be assessed and fixed. Furthermore, while our glucose sensor is not functional,               
we have learned what new directions students could go in to make the sensor work if they chose                  
to continue this project.  
 
8.2 Future Work 
Some possible directions to go in the future include:  
● Microcontroller Implementation: Due to time constraints we were not able to           
implement the microcontroller into our PCB. While we did developed a possible            
schematic for implementation, there is more work that needed to be done in terms of               
coding before we got a fully functional microcontroller. Due to time constraints we opted              
to continue to use the Arduino Uno as our microcontroller. For future development of the               
project, a team could potentially implement this change which would bring down the             
overall price of the project by getting rid of the need for an Arduino Uno. (​See Appendix                 
D for Microcontroller Circuit Design) 
● Software Development: For most of our computations we use an assortment of software             
including Arduino Software and Matlab. A goal for the future is to create a iOS or                
Android app that is able to do all of the necessary calculations to send the data results to                  
another mobile device. 
● Adding in respiratory sensor. 
● Using a new methodology to test glucose levels. 
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Chapter 9: Ethical Analysis 
  
When it comes to engineering, it can be easy to lose oneself in the excitement of new and                   
upcoming technologies. At times, however, these ideas can overshadow the equally important            
concept of ethical considerations. Just as important as the newest medical treatment are the              
questions that surround it, such as who has access to this treatment, whether the risks outweigh                
the benefits, and other such ethical questions that helps draw the line between a “good”               
technology and a “bad” one. The technology in question is the Vital Multi-Sensor Kit, which will                
measure vital signs such as heart rate, blood pressure, and other baseline vitals, and be               
connectable to a mobile device to be sent to a physician for diagnosis. 
To start off, it is important to understand the fundamental moral argument for pursuing               
the senior design project that this team is undertaking. This argument is that every person has a                 
fundamental dignity, and that dignity extends to a right to medical care. Basic human dignity               
means treating every life as if it matters, whether that is socially, intellectually, or physically. So                
long as a life matters, that means that there must be certain steps that we as people must be                   
prepared to take to uphold this dignity. With this in mind, we sought to make it easier for people                   
to get access to the health care they need, even if it is just for the sake of treating them with basic                      
human dignity. Beyond that yet, there are an immense number of people around the world who                
take their access to healthcare for granted, primarily in the developed world. If there are so many                 
who believe healthcare is a right as opposed to a privilege, then we should treat it as such, and                   
work to defend this right for those who cannot necessarily do so themselves. 
Moving onto the product itself, the ethical duty that this team has to the potential users                 
must be considered. Ideally, the product this team is working towards producing would target a               
very large demographic, which is those who do not have easy access to a doctor or hospital, but                  
do have access to a smartphone or other such mobile device. This could be easily in the millions                  
of people. What is owed to these potential users is that the data they retrieve from the device is                   
accurate to the best of our ability. Inaccurate data could result in either a false sense of security                  
in one’s health, or an unnecessary amount of time and resources spent on getting to a hospital                 
when such a visit is not necessary. This is not to say that absolute accuracy can be achieved for                   
this product, but it is to say that it is the ethical duty of this team to work towards the greatest                     
accuracy given the time and resources allotted, and provide the appropriate specifications for the              
percent error they would be likely to encounter. Another duty to the potential users is that the                 
product should be made to fulfill the requests and needs as much as possible. Given that we will                  
be contacting some of the potential users of this product, it is our duty to provide them with a                   
product that at least attempts to meet the user's’ needs, as opposed to whatever desires this team                 
may have for the product. 
Yet another important ethical consideration when engineering a product is the risks that              
may be associated with it. To the best of our ability, we are ensuring that this device would not                   
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be able to malfunction to the extent that it could cause physical harm. While there are a few parts                   
that have the potential to heat up when overused that could burn the skin, we are going to                  
minimize the risk of that within the circuitry of the product. This occurrence will also be                
minimized by the elimination of physical contact with any electrical components that could heat              
up. There is also a risk associated with the product with regards to confidentiality. Since the                
purpose of this device is to collect baseline vital signs that could be indicative of health concerns,                 
the data retrieved by the device would be considered confidential.The purpose of this product is               
to collect and send health data to a desired person via mobile device; at least in part, steps ought                   
to be taken to ensure that this data cannot be acquired by unauthorized viewers, which could be                 
accomplished with data encryption methods. This is a concern because this confidential health             
data could be indicative of health concerns, which is data that is valuable to health and life                 
insurance companies, as well as other parties that could misuse the data. Lastly, there is the risk                 
brought up earlier, about the potential harms of inaccurate data. Should the product provide data               
that is indicative of no health concerns when there are in reality concerns, there is potential for                 
the user to miss out on treatment for an ailment they may be suffering from. At the same time, if                    
the product provides data that is indicative of a health concern when there is no health risk, the                  
user may make arrangements to make their way to a hospital without the need for a potentially                 
costly trip. 
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Appendix A: Raw Data 
 
Heart Rate & Pulse Oximeter Data 
 
Table A-1: Pulse Oximeter and Heart Rate Data from Trial 1.  
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Table A-2: Pulse Oximeter and Heart Rate Data from Trial 2. Elevated heart rate and oxygen 
saturation measurements are also shown. [SD = Senior Design Device] 
Patient 0 HR 80 
  O2 98 
HR_SD 52 
O2_SD 99 
HR0_elev 97 
O2_elev 98 
HR_SD_elev 108 
O2_SD_elev 99 
Patient 1 HR 64 
  O2 99 
HR_SD 68 
O2_SD 98 
HR_elev 62 
O2_elev 98 
Patient 2 HR 95 
  O2 99 
HR_SD 96 
O2_SD 99 
HR0_elev 110 
O2_elev 98 
HR_SD_elev 108 
O2_SD_elev 98 
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Blood Pressure Data 
 
Table A-3: Trial 1 and Trial 2 of Blood Pressure Sensor Measurements 
Trial 1 Person 1 Person 2 Person 2 Person 4 
Commercial BP:  119/77 102/70 107/72 103/65 
Sensor: 110/65 98/72 100/67 98/67 
% Diff (Systolic) 8% 4% 7% 5% 
% Diff (Diastolic) 16% 3% 7% 3% 
     
Trial 2 Person 1 Person 2 Person 2  
Commercial BP:  116/72 98/73 100/60  
Sensor: 92/63 100/67 93/61  
% Diff (Systolic) 21% 2% 7%  
% Diff (Diastolic) 13% 8% 2%  
Avg. Error Systolic  8%   
Avg. Error Diastolic  7%   
 
 
 
Figure A-1: This is an example graph of the blood pressure sensor readings. The beginning of the 
heart rate marks the systolic pressure, and the diastolic pressure is where the heart beat ends. 
Heart beats are most visibly seen around 1500 (in the x-direction).  
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Glucose Sensor Data 
 
Table A-4: Glucose Sensor Raw Data Trial 1 
Trial 1 Glucose Concentration (mg/dL) Signal (0 to 1023) Baseline (bits) 
 200 660 837 
 90 655 839 
 50 656 839 
 
Table A-5: Glucose Sensor Raw Data Trial 2 
Trial 2 Glucose Concentration (mg/dL) Signal (bits) Baseline (bits) 
 30 22 735 
 50 10 728 
 70 11 722 
 100 10 727 
 125 10 705 
 200 9 696 
 
Table A-6: Glucose Sensor Raw Data Trial 3 
Trial 3 Glucose Concentration (mg/dL) Signal (bits) Baseline (bits) 
 100 387 696 
 30 289 700 
 200 308 700 
 200 295 700 
 100 389 670 
 30 382 699 
 
Table A-7: Glucose Sensor Raw Data Trial 4 
Trial 4 
Glucose Concentration 
(mg/dL) Signal (bits) Baseline (bits) 
 30 634 650 
 50 636 651 
 70 636 651 
 80 634 651 
 90 636 651 
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Table A-8: Glucose Sensor Raw Data Trial 5 
Trial 5 
Glucose Concentration 
(mg/dL) Signal (bits) Baseline (bits) 
 50 408 585 
 90 403 584 
 125 399 584 
 200 400 584 
 
Table A-9: Glucose Sensor Raw Data Trial 6 
Trial 6 
Glucose Concentration 
(mg/dL) Signal (bits) Baseline (bits) 
 50 176 585 
 90 N/A 584 
 125 N/A 584 
 200 132 584 
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Appendix B: Detailed Calculations 
 
Blood Pressure Calculations: 
Blood pressure data retrieved directly from the sensor without any processing is returned in the 
form of bits, ranging from 0 to 1023. These bits are directly correlated to the voltage output of 
the sensor, which can be calculated using the formula: 
 
# of  bits)V = ( × (5V )(1023 bits)  
 
where V is equivalent to the voltage output of the pressure sensor in volts. In order to now 
retrieve a pressure value from the pressure output, the voltage must be processed through a 
formula provided by the manufacturer of the pressure sensor (see Figure I-1), which is: 
 
0.018 .04)V out = V s × ( × P + 0  
 
where V​out​ is representative of the voltage output of the pressure sensor in volts, V​s​ is 
representative of the voltage provided to the sensor in volts, and P is the pressure applied to the 
sensor in kilopascals (kPa). To solve for the pressure P in millimeters of mercury (mm Hg) 
which is standard for blood pressure sensors in the United States, the equation is changed into: 
 
.222) .5P = ( V out0.0594 − 2 × 7  
 
where P is pressure in mmHg, and V​out​ is the voltage output of the pressure sensor in volts.  
 
Then, in order to extrapolate the systolic and diastolic pressures, the pressure values of a single 
trial must be graphed. On this graph, the relevant region of the data set is then identified, marked 
by the appearance and subsequent disappearance of small peaks during the slow release of 
pressure.  
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Figure B-1: Blood pressure graph breakdown 
 
With this relevant region identified, the first and last substantial peaks are identified. The 
pressure of the first substantial peak is representative of the systolic pressure, and the pressure of 
the last substantial peak is representative of the diastolic pressure. The key with this 
identification of substantial peaks is the amplitude of the peaks. The very first small peaks that 
appear are not consistent with the systolic blood pressure, but the first peak of a relatively 
substantial amplitude is consistent with the systolic pressure (as measured against commercial 
blood pressure sensors). This analysis is the same with the diastolic pressure. Since there are 
variations in the amplitudes of the peaks from person to person and trial to trial, the 
determination of what constitutes a significant enough amplitude to qualify as a substantial peak 
is relatively subjective, which is the reason that at this point, the MATLAB code is not able to 
accurately determine the systolic and diastolic pressures from the data sets. Hence, the 
calculations are done through Excel and visual analysis reveals the relatively substantial peaks to 
indicate the pressure values of interest. 
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Appendix C: System-Level Descriptions 
 
 
Figure C-1: Initial Blood Pressure Breadboard Design 
 
 
Figure C-2: Pulse Ox Breadboard Implementation 
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Figure C-3: Initial Glucose Breadboard Design 
 
 
Figure C-4: Final PCB with all Circuits Included 
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Figure C-5: Final Blood Pressure Testing 
 
 
Figure C-6: Final Pulse Oximetry Testing 
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Figure C-7: Continued Glucose Testing 
 
Table C-1: Example of Blood Pressure Accuracy Comparison 
Trial 1  
 Person 1 Person 2 Person 3 Person 4 
Commercial BP 119/77 102/70 107/72 103/65 
Sensor 110/65 98/72 100/67 98/67 
% Difference  
(Systolic) 7.6 3.9 6.5 4.9 
% Difference 
(Diastolic) 15.6 2.9 6.9 3.1 
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Figure C-8: Glucose PCB Implementation 
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Appendix D: Circuit Designs 
 
Figure D-1: ExpressPCB Blood Pressure Circuit Design 
 
Figure D-2 : ​ExpressPCB ​Oximeter Circuit Design 
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Figure D-3: Glucose Experimental Circuit Design 
 
Figure D-4: ​ExpressPCB ​LED Drivers Circuit Design 
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Figure D-5 :​ ​ExpressPCB Microcontroller Circuit Design 
 
 
Figure D-6: PCB Layout 
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Table D-1: Sensor Circuit Filters, Amplifiers, and Buffers 
Blood Pressure Circuit 
Type of Filter/Buffer/Amplifier Cut Off/Gain 
Low Pass 10.6 Hz 
Buffer  
High Pass 2.19 Hz 
Non-Inverting Amplifier 101 Gain 
Low Pass 10.6 Hz 
Glucose Sensor Circuit 
Transimpedance Amplifier 0.25Hz Cut Off/ 100 Gain 
Oximeter Circuit 
Buffer  
Low Pass  5.89 Hz 
Notch Filter  60 Hz 
High Pass  0.86 Hz 
Non-Inverting Amplifier 31 Gain 
Low Pass  4.82 Hz 
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Appendix E: Project Management 
Project Timeline:  
 
Figure E-1: Gantt Chart of Senior Design Project (Year-long)  
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IRB Application 
Advisor: ​Dr. Ashley Kim 
Students: ​Natalie Arrizon, Jose Hernandez, Antonio Maldonado-Liu, Alejandra Pacheco 
IRB Application 
 
Title: Vital Sensors Project  
1. Purpose  
Provide a brief explanation of the proposed research, including specific study hypothesis, 
objectives, and rationale.  
 
The purpose of the research is to increase accuracy with the vital sensors kit that our team is 
designing. The kit will have the capability to measure up to six vital signs through the use of 
around 3-4 separate sensors. Testing on human subjects will help to ensure accuracy through the 
measured results that are collected through different patients. By collecting data with more 
subjects, our team will be able to increase the accuracy of the measured data by altering our 
original design or accounting for other setbacks or factors.  
 
2. Background 
Give relevant background (e.g., summarize previous/current related studies) on condition, 
procedure, product, etc. under investigation, including citations (attach bibliography in 
Attachments section) if Applicable. 
 
In many developing countries, a large percentage of the population lacks access to adequate              
healthcare. This is especially true in India where close to 70% of the population lives in rural                 
areas and has little to no access to hospitals or clinics. At the same time the doctor to patient ratio                    
is of 0.6 to 1000. 
 
Telemedicine has slowly been implemented in India to make doctors more available for patients              
through the use of video conferences and other forms of communication. However, a             
shortcoming of this is that the doctor still has no direct access to a patient's information, other                 
than descriptions, x-rays, etc. 
 
Around 80% of the population in India owns some form of mobile device, only 30% of those                 
devices are smartphones. This percentage is expected to increase. Currently India is the second              
largest smartphone market globally. 
 
In 2016, a team of Santa Clara students designed a vital sensory kit that could be connected to a                   
computer to measure vital signs. The device was able to measure blood pressure, oxygen              
saturation, and heart rate with an average of 13% error. This year, we seek to produce a device                  
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with reduced error, and that has the capability to connect to a mobile phone for mobile vital sign                  
monitoring.  
 
3. Collaborative Research 
N/A 
 
4. Qualifications of Study Personnel 
 
a) There are four students working on this kit who have qualifications well suited for the 
project. Two bioengineering majors help provide knowledge on how to work with the 
medical sensors and have the capability to read and distinguish proper results. One of the 
bioengineers is also EMT certified. The two electrical engineers are experienced in 
designing various types of circuitry and filter design. 
b) The students have taken ELEN 21, ELEN 50, and other electrical engineering courses 
that are relevant to designing the proper circuit models and analyzing data that is 
collected. ELEN 21 is about logic design, and ELEN 50 is an introductory course to 
electricity and circuits. The two electrical engineering majors are also experienced in 
designing PCB boards and have training in the use of oscilloscopes, multimeters, bread 
boards, sensors, and other relevant programming. The bioengineering students have taken 
BIOE 163, which prepares students with the fundamentals for device engineering in the 
industry and BIOE 162, a class geared towards understanding signals and signal 
processing with Matlab. All members of the team are capable with working with patients 
in a professional and friendly manner to carry out the research necessary. 
 
5. Subject Population 
a) Describe proposed subject population, stating age range, gender, race, ethnicity, language and 
literacy. 
The population we will be testing mostly consists of university students of an age range of 18-24. 
The expected sample of subjects will be chosen so that there is a diverse range of races, 
ethnicities and ages, and sex.  
  
b) State total number of subjects planned for the study and how many must be recruited to obtain 
this sample size. Explain how number of subjects needed to answer the research question was 
determined. 
 
The total number of subjects that will be tested will be 30. We will be recruiting 30 subjects to 
obtain the sample size. The amount of subjects to be tested was determined based on the time 
constraints of the project.  
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c) If any proposed subjects are children/minors, prisoners, pregnant women, those with physical 
or cognitive impairments, or others who are considered vulnerable to coercion or undue 
influence, state rationale for their involvement. 
 
NA 
 
6. Recruitment 
a) Explain how, where, when, and by whom prospective subjects will be identified/selected and 
approached for study participation. If researcher is subject's instructor, physician, or job 
supervisor, or if vulnerable subject groups will be recruited, explain what precautions will be 
taken to minimize potential coercion or undue influence to participate. 
 
Subjects will be randomly selected and approached during daylight hours at Santa Clara             
University. Each team member will also ask their friends or acquaintances to participate in the               
study. We will be conducting the tests in a non-agitating environment. Some subjects will be               
asked to exercise before testing. Over the period of time between January 2017 to March 2017. 
 
b) Describe any recruitment materials (e.g., letters, flyers, advertisements [note type of 
media/where posted], scripts for verbal recruitment, etc.) and letter of permission/cooperation 
from institutions, agencies or organizations where off-site subject recruitment will take place 
(e.g., clinic, school district). Attach these documents in Attachments section. 
 
We will be asking most subjects in an informal manner to participate in the testing of our device. 
Verbal confirmation will be the only thing needed as each subject being approach is a consenting 
adult.  
 
7. Screening 
a) Provide criteria for subject inclusion and exclusion. If any inclusion/exclusion criteria are 
based on gender, race, or ethnicity, explain rationale for restrictions. Provide criteria for subject 
inclusion and exclusion. If any inclusion/exclusion criteria are based on gender, race, or 
ethnicity, explain rationale for restrictions.  
 
a) The goal is to have a diverse group to conduct our research on. We would like to have 
about a 50% male 50% female ratio to help detect any nuances in heart rate or blood 
pressure, should there be any. Our subjects will also be more varied based on age as to 
get a broad spectrum of results to improve accuracy within the device. 
 
b) If prospective subjects will be screened via tests, interviews, etc., prior to entry into the 
"main" study, explain how, where, when, and by whom screening will be done. NOTE: Consent 
must be obtained for screening procedures as well as "main" study procedures. As appropriate, 
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either: 1) create a separate "Screening Consent Form;" or 2) include screening information within 
the consent form for the main study. 
 
b) There will be no screening conducted prior to the study.  
 
8. Compensation and Costs 
a) Describe plan for compensation of subjects. If no compensation will be provided, this should 
be stated. If subjects will be compensated for their participation, explain in detail about the 
amount and methods/ terms of payment. 
 
There will be no compensation for students. Students will participate in study on a volunteer 
bases.  
 
9. Study Procedures 
a) Before any subject is tested they will be fully informed of the experiment, what we are 
doing for our project, the exact procedure they will be participating in, as well as offer an 
answer to any other question they might have. Without question, any subject that feels 
cautious or uncomfortable about participating in our study are advised not to participate. 
The patient then must also sign a consent form in order to participate in the experiment.  
 
1. We will first measure the resting heart rate, blood pressure, glucose and oxygen 
saturation levels simultaneously, temperature, and finally elevated heart rate. The testing 
will be performed by Alejandra Pacheco, Natalie Arrizon, Jose Hernandez, or Antonio 
Maldonado-Liu unless otherwise specified. The testing will occur in Benson 1, in the 
basement of the Benson Center, with the exception of the blood glucose testing, which is 
to occur in the Cowell Center, as stated below. Testing will occur in the window of 
January 2017 - March 2017, between 9am - 5pm on any day of the week. Each patient 
will be tested no more than twice total, no more than once per week. The testing process 
itself should be under one hour, with the informing and consent form signing taking 
approximately fifteen minutes. There will be no deception or lack of full disclosure, and 
no audio or video recording.  
a. Elevated Heart Rate: to achieve this condition, we will ask the subject to perform 
any activity of their choice that will elevate their heart rate (i.e. push-ups, jog in a 
circle, high-knees, walking, etc.) for 1 minute. 
Resting Heart Rate: When taking readings from this condition, we will ask the 
subject to sit comfortably and to relax for 2 minutes so that they are as close to a 
resting heart rate as possible. This will likely be done first, prior to the other two 
conditions which should likely elevate the heart rate.  
b. Once the desired state is achieved,  
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2. Blood Pressure: The blood pressure cuff is placed on the non-dominant upper arm of the 
patient, with the sensor over the brachial artery. Antonio Maldonado-Liu will then use the 
hand pump to manually inflate the blood pressure cuff to approximately 160mmHg, at 
which point the slow release of the air pressure will be activated, and the device will 
measure the patient’s blood pressure. After 2 minutes, the patient’s dominant arm will be 
tested with a commercial blood pressure device, also by Antonio.  
3. **Glucose levels: The measuring component for this and the pulse oximetry are the 
same. The earlobe component is applied to the earlobe of the patient. The measuring will 
be activated, and the device will measure the blood glucose levels non-invasively and 
spectroscopically.  
4. Oxygen saturation: With the earlobe sensor in place on the patient’s earlobe, the 
measuring is activated. The device will then measure the blood oxygen saturation of the 
patient spectroscopically (industry standard). The patient’s blood oxygen saturation is 
simultaneously measured using a commercial finger pulse oximeter on the middle finger 
of their right hand.  
5. Temperature degree: The patient places the thermometer in the armpit of the right arm, 
and the patient holds the thermometer in position with the right arm. The thermometer is 
then activated and is left in place until a stable temperature reading is reached (no change 
in temperature reading for 5 seconds). This measurement is taken simultaneously with a 
commercial axial thermometer in the patient’s left armpit.  
 
**The non-commercial blood glucose monitor that we are using in our device is experimental. 
Traditional commercial blood glucose devices require the exposure of blood in order to 
invasively measure the blood glucose concentration enzymatically. Our blood glucose device 
instead uses a near-infrared LED and a corresponding photodiode to measure the transmittance 
of the light through the earlobe tissue without the necessity of exposing any blood, and is in this 
way completely non-invasive.  
 
Final note: We are in the process of designing and building a prototype of each sensor and will 
produce a final prototype for testing patients. The project timeline is attached in the form of a 
Gantt Chart.  
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CITI Training Report 
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School of Engineering Budget Proposal 
 
Vital Multi-Sensor Kit, Funding Proposal 
 
Group Members 
 
Name Major Email 
Alejandra Pacheco (Primary) BIOE a2pacheco@scu.edu 
Antonio Maldonado-Liu BIOE acmaldonadoliu@scu.edu 
Jose Hernandez ELEN jhernandez@scu.edu 
Natalie Arrizon ELEN narrizon@scu.edu 
Ashley Kim BIOE Advisor ukim@scu.edu 
Tokunbo Ogunfunmi ELEN Advisor togunfunmi@scu.edu 
 
Our Vision to Give Developing Countries Tele-mobile Access to Healthcare 
 
The purpose of the Vital Sensors Kit is to be inexpensive and accessible to people in rural areas                  
of developing countries, where there is no easy access to medical care. The kit is aimed to be a                   
simple and affordable medical device that monitors vital signs such as blood pressure, blood              
oxygen concentration, heart rate, respiratory rate, blood glucose, and temperature without the            
need for a doctor’s immediate assistance. In such scenarios, this device would replace the first               
steps of any standard medical checkup. Instead of traveling all the way to a hospital to have                 
baseline vitals measured, you would measure them with this device, and send them to a               
physician for review to help determine whether an in-person appointment is necessary. This             
frugal device gives under-resourced families the opportunity to take care of their health and live               
a better life.  
 
By having a medical kit that takes many important vital signs, even people who do not have                 
insurance or easy access to a hospital will be able to monitor their own vital signs and those of                   
their family members. This solution is better than others currently available because it is much               
smaller, cheaper, and more intuitive in design and use. Current devices include those carts that               
are used in most hospitals here in the US, that are about 3 feet tall, and probably cost well into                    
the hundreds of dollars, if not over a thousand. There are a number of other available devices,                 
but they are expensive, and generally only have one or two types of sensors. The proposed                
device is targeted to cost no more than $150, will contain at least four sensor types, and be                  
connectable to a mobile device such that data can be sent wirelessly to a physician via Wi-Fi or                  
SMS. Communities can share multiple vital sensor kits and split costs accordingly to make the               
device even more affordable. We strongly believe that by making this device low-cost and              
simple to use for developing countries, communities and families will be much happier and              
healthier because they will be able to get the medical attention they need from doctors without                
having to have the financial burden of paying for multiple hospital visits and transportation costs.  
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List of Funding Sources 
 
● Undergraduate SOE Funding 
○ $606 
 
Budget 
 
Item Number of 
Items 
Price per 
Unit 
Anticipated 
Total Cost  
Commercial Pulse Oximeter (for comparison 
to created pulse oximeter)  
Santamedical SM-240 OLED Finger Pulse 
Oximeter 
1 $46 $46 
Commercial Blood Pressure Monitor (for 
comparison to created blood pressure 
monitor)  
Omron 7 Series Upper Arm BP Monitor 
1 $75 $75 
Commercial Glucose Monitor (for comparison 
to created glucose meter)  
One Touch Ultra Diabetes Testing Kit - 
One Touch Ultra Meter, 100GenUltimate 
Test Strips, 100 30g Lancets, 1 Lancing 
Device and 100 Alcohol Prep Pads 
1 $41 $41 
Commercial Thermometer (For comparison to 
created thermometer) 
Beyoung Axillary Thermometer 
1 $18 $18 
Commercial Stethoscope 
Omron Sprague Rappaport Stethoscope 
1 $14 $14 
Electret Microphone 
COM-0835 ROHS 
5 $1.00 $5 
Custom 2-layer circuit board from 
ExpressPCB.com ( PCB boards) 
3 $25 $75 
5mm Red LED ​(660nm) 10 $0.30 $3 
 
5mm IR LED ​(940nm)  10 $0.80 $8 
Glucose Meter LED 
LED1550E - Epoxy-Encased LED, 1550 nm, 
5 $18 $90 
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2.0 mW, T-1 ¾  
GPD Optoelectronics GAP 136 in GaAs 
Photodiode ​(900-1650nm) 
1 $25 $25 
TI OPT101P Photodiode ​(400-1100nm) 2 $7.50 $15 
Thermistor: 
TI LMT70A Analog Temperature Sensor 
5 $2.80 $14 
Honeywell ASDX015PDAA5  ​Transducer 1 $44 $44 
Silver (415) - Sport Knitting Wool & Yarn 1 roll $7 $7 
Dritz 9507B Non-Roll Woven Elastic, Black, 
1-Inch 2.5 yards $3 $3 
Meguiar's W0004 Foam Applicator Pad 4-1/2" 4 $4 $4 
3Way Dump Valve 2 $2 $4 
 
Valve Noninverting OpAmp 2 $1.50 $3 
Handpump 5 $1 $5 
Chip Components: Resistors, Capacitors, 
Inductors, etc. (DigitKey.com)  
As needed Resistors: 
$10 
Capacitors: 
$10 
Inductors: 
$10 
Other: 
$10 
$40 
Arduino Mega Microcontroller 1 $40 $40 
Breadboard 1 $9 $9 
Total cost:  $588 
Shipping and taxes $110 
Total cost:  $698 
Total amount requested from SOE:  $698 
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School of Engineering Participation Statement 
 
We all recognize and commit to presenting our project in poster form at Family Weekend in 
February, as well as Preview Weekend and Spring Engineering Education Days in April, should 
the Dean’s Office commit any funds to this project.  
 
Team Member Signatures 
 
 
_______________________________________________ 
 
_______________________________________________ 
 
_______________________________________________ 
 
_______________________________________________ 
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Advisor Approval Statement 
 
I have reviewed and approve of the above budget proposal to the School of Engineering for the 
Senior Design Thesis. 
 
______________________________________________        Date:_____________________ 
 
______________________________________________        Date:_____________________ 
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Meeting Minutes 
10.04.16 
Members Present: Antonio, Natalie, Jose, Alejandra 
 
- Setting up meeting with Uma and Makenzie at 1:45 in Engineering Design.  
- Meet with Dr. Ogunfumi at 4 pm; EC  
 
Meeting with Dr. Ogunfumi 
- He will send us the thesis where students used body signals to make music.  
Try to ​aim​ high and think of a lot of improvements/changes to make: creativity brainstorm 
session.  
- Tuesday meetings 11:15 to 11:45 with Dr. Ogunfumi  
 
10.11.16 
Ideas:  
- Making the pulse oximeter sensor (ring, on the ear lobe)  
- Respiratory rate sensor (to figure out at least if something is wrong)  
- ECG for developing countries (3 electrodes)  
- Calibration-free Pulse Oximeter 
Tony:  
- Reduce the cost of the components 
- Get a smaller microcontroller 
- Improve the accuracy of the sensors (look into doing more human testing) 
- Adding another sensor (respiratory rate)  
- Improving efficiency and speed of the code 
- Detectable by mobile device 
Jose: 
- Make your own PCB 
- Using Arduino UNO??  
● We finally met with the EWH people and they are going to try to help us.  
● Recommend taking: Mechatronics (winter), VSP (spring), 
● Dr. Kim is going to contact us with the files available  
 
10.18.16 
● SOE Funding Proposal - due 10/21 
● Finally got access to Google Drive 
To-Do’s: 
- Look at Neo Panda website 
- Look into Google Drive folders and look into what they did. 
- Preliminary designs. 
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10.20.16 
- Contact Elizabeth to get to them.  
- Set up an interview with questions that are needed.  
- Specific diseases or groups  
- Look into similar organizations 
- Build design prototype and order everything by Christmas break.  
- Add in Arduino and also other sensors for respiratory rate. 
- Electrodes for respiratory rates.  
 
 
10.27.16 
● Email SWASTH 
● Email Roberto Clemente Clinic  
● Email Noora Health 
○ Cc Dr. Kim 
○ Having them finding the non-profit. 
○ Having them both be on the call. 
● No change in parameters yet.  
To Do: 
● Contact Noora Health directly and indirectly 
● Start ordering components 
● Global Innovation Exchange 
 
11.12.16 
Ear piece that would have both the pulse oximeter reading and the glucose reading  
What plastics are used for pulse oximeters? We don’t want the photodiode to overheat.  
 
  
11.17.16 
Still need to meet with Noora Health and HeMoClo people ***  
Still need to decide what the goals are for the respiratory rate. 
Work on the IRB application 
  
11.30.16  
Goals: 
Start IRB Application  
Come up with questions for meeting with Katy 
Edit future timeline (for winter break)  
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02.01.17 
Accomplishments:  
Set up meeting dates with advisor 
Created weekly goals for the quarter 
Started the SolidWorks design. 
Turned in the IRB application for human testing. 
Goals:  
Finish the SolidWorks design by next week and get trained in the Maker Lab to be able to print 
the products.  
Start testing commercial equipment. 
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Santa Clara University Bioengineering Department 
Vital Multi-Sensor Kit Consent Form 
 
Explanation 
Alejandra Pacheco, Antonio Maldonado-Liu, Jose Hernandez and Natalie Arrizon are 
bioengineering and electrical engineering students, working together as a senior design team here 
at Santa Clara University under the direction of Dr. Ashley Kim. We are conducting a research 
study to verify the validity of the four sensors we built to make up one affordable vital sensor kit 
for developing countries. Thirty subjects total will be tested. Each subject’s heart rate, blood 
oxygen saturation and pressure will be measured with the vital sensor kit device and then 
measured again with the commercial devices. The glucose concentration will be measured 
non-invasively only with our ear sensor. 
  
We are requesting your participation, which will involve the use of two blood pressure sensors, 
two pulse oximeters (one on your finger, one on your earlobe), and an experimental non-invasive 
blood glucose sensor which will also go on your earlobe. Each testing session will take no more 
than forty-five minutes, and you will be tested no more than once per week, a maximum of twice 
total. Your participation in this study is voluntary.  If you choose not to participate or to 
withdraw from the study at any time, there will be no penalty.  It will not affect your grade or 
status with the university. In addition, we will ensure that all health data will remain private.  If 
you choose to sign the consent form, we will assign a number to your name. During testing 
periods, we will record all data according to your given number. Our advisor Dr. Kim will have 
the list of names-to-numbers and will be the only one to access the data. Upon completion of this 
project, the list will be destroyed. The results of the research study may be published, but your 
name will not be used. 
  
The procedure is as follows: 
The subject will be fully informed of the experiment, including what we are doing for our 
experiment, why we are doing it, as well as how each of the sensors works. Any questions that 
the subject has prior to beginning the measurements will be answered. To reiterate, should the 
subject at all uncomfortable with any part of the experiment or procedure, they are advised not to 
participate. 
  
Resting heart rate: When taking readings from this condition, we will ask the subject to sit 
comfortably and to relax for 2 minutes so that they are as close to a resting heart rate as possible. 
Both pulse oximeters, one to the middle finger of the right hand, and the other to the earlobe, will 
be applied simultaneously to measure the heart rate of the subject in this state. 
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Elevated heart rate:  To achieve this condition, we will ask the subject to perform any activity of 
their choice that will elevate their heart rate (i.e. push-ups, jog in a circle, high-knees, walking, 
etc.) for 1 minute. The pulse oximeters will then be applied in the same fashion as the resting 
heart rate condition, to record the heart rate of the subject. 
  
Blood oxygen saturation: This measurement will occur at the same time as the resting heart rate 
measurement. With the subject resting and breathing normally, their blood oxygen saturation will 
be recorded via the pulse oximeters already reading the subject’s heart rate. 
  
Blood pressure: The blood pressure cuff is placed on the non-dominant upper arm of the patient, 
with the sensor over the brachial artery. Antonio Maldonado-Liu will then use the hand pump to 
manually inflate the blood pressure cuff to approximately 160 mmHg, at which point the slow 
release of the air pressure will be activated, and the device will measure the patient’s blood 
pressure. After 2 minutes, the patient’s dominant arm will be tested with a commercial blood 
pressure device, also by Antonio. The commercial device performs the same procedure in an 
automated fashion. 
  
Blood glucose concentration: The measuring component for this and the pulse oximetry are the 
same. The earlobe component is applied to the earlobe of the patient. The measuring will be 
activated, and the device will measure the blood glucose levels non-invasively and 
spectroscopically. 
  
The testing will occur in Benson 1, in the basement of the Benson Center. 
  
Risks and Discomforts 
Participation in this experiment is completely voluntary.  If you choose not to participate or to 
withdraw from the study at any time, there will be no penalty.  It will not affect your grade or 
status with the university.  You may choose to cease the experiment at the elevated heart rate 
measurement, as the exercise may be uncomfortable for you. Once again, withdrawal at this 
stage or any other for any reason will have no penalty upon you. 
  
Benefits of our Research 
Although there may be no direct benefit to you, the possible benefit of your participation will be 
furthering the progress towards making blood glucose monitoring completely painless. In 
addition, this product seeks to increase accessibility of health data and ease health monitoring at 
a lower cost to the user. There will also be increased communication between health 
professionals and patients, for an overall reduction in unnecessary visits to the hospital and 
potentially increased health consciousness. 
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Confidentiality 
The results of this research study may be published, but your name will not be used. In order to 
maintain confidentiality of your records, at the beginning of the data collection process, we will 
only have the number matching the subject’s name. This will allow us to omit the names of the 
subjects in every part of the experiment and thesis. No names will be written down, and all 
consent forms collected will be delivered to Dr. Ashley Kim of Santa Clara University’s 
Bioengineering Department, separate from the data and all other components of the experiment. 
This will be done to keep the subject’s identity and data confidential. 
  
If you have any questions about your rights as a subject/participant in this research, or if you feel 
you have been placed at risk, you can contact the Chair of the Human Subjects Committee, 
through Office of Research Compliance and Integrity at (408) 554-5591. 
Inquiries 
If you have any questions or doubts, please ask us for explanations. If the subject has any 
questions regarding the design they may call Alejandra Pacheco at (408) 667-6770. Or, our 
advisor, Dr. Ashley Kim, may be contacted at (408) 554 - 2760. 
  
CALIFORNIA EXPERIMENTAL SUBJECTS BILL OF RIGHTS 
As a research participant you have the following rights. These rights include but are not limited 
to the participant's right to: 
●      be informed of the nature and purpose of the experiment; 
●      be given an explanation of the procedures to be followed in the medical experiment, and 
any drug or device to be utilized; 
●      be given a description of any attendant discomforts and risks reasonably to be expected; 
●      be given an explanation of any benefits to the subject reasonably to be expected, if 
applicable; 
●      be given a disclosure of any appropriate alternatives, drugs or devices that might be 
advantageous to the subject, their relative risks and benefits; 
●      be informed of the avenues of medical treatment, if any available to the subject after the 
experiment if complications should arise; 
●      be given an opportunity to ask questions concerning the experiment or the procedures 
involved; 
●      be instructed that consent to participate in the medical experiment may be withdrawn at any 
time and the subject may discontinue participation without prejudice; 
●      be given a copy of the signed and dated consent form; and 
●      be given the opportunity to decide to consent or not to consent to a medical experiment 
without the intervention of any element of force, fraud, deceit, duress, coercion or undue 
influence on the subject's decision. 
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Representation of Health and Assumption of Risk 
I have read the foregoing information, and I understand the exercise procedures that I will be 
asked to perform. I agree to participate in exercise. I warrant and represent that I am in good 
health and that I am able to physically perform the exercise required of me. Knowing the risks, I 
hereby agree to assume such risks and to release and hold harmless all persons and entities that 
might be liable to me, my heirs, or assigns for damages. All questions have been answered to my 
satisfaction. 
  
In order to achieve the elevated heart rate described above, we will ask the subject to perform 
any activity of their choice that will elevate their heart rate (i.e. push-ups, jog in a circle, 
high-knees, walking, etc.) for 1 minute. 
  
Are you fit to perform this activity? Check one that applies to you. ☐ Yes ☐ No 
  
Freedom of Consent 
I have also been informed that the information derived from this procedure is confidential and 
will not be disclosed to anyone other than the researchers involved with this study. The 
information obtained, however, may be used for a statistical or scientific purpose with my right 
of privacy retained by not disclosing any identifying information. 
  
Participant Name: ___________________________________________ 
  
Signature:_________________________________________________ Date: ____________ 
  
  
Person Obtaining Consent 
I attest that the requirements for informed consent for the medical research project described in               
this form have been satisfied – that the subject has been provided with the experimental               
Subject’s Bill of Rights, if appropriate, that I have discussed the research project with the subject                
and explained to him or her in non-technical terms all of the information contained in this                
informed consent form, including any risks and adverse reactions that may reasonably be             
expected to occur. I further certify that I encouraged the subject to ask questions and that all                 
questions asked were answered. 
  
Signature of Person Obtaining Consent: 
  
__________________________________________ Date: ____________ 
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Appendix F: Electrical Components 
 
Component Tables: 
 
Oximeter Filter 
C1 270pf 
C2 10uf 
C3 0.22uf 
C4 0.1uf 
C5 0.1uf 
C6 3.3uf 
C7 5600pf 
C8 10uf 
C9 0.1uf 
C10 1uf 
R1 1.2k 
R2 10k 
R3 4.7M 
R4 2.7k 
R5 27k 
R6 27k 
R7 14k 
R8 56k 
R9 150k 
R10 4.7M 
R11 3.3k 
R_Vres_1 10k 
R_Vres_2 10k 
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Transimpedance Op 
213 
http://www.ti.com/general/docs/lit/getliterature.tsp?genericPart
Number=opa381&fileType=pdf 
LEDs Drivers 
R_LED1m 1k 
R_LED2m 1k 
R_LED3m 1k 
R_LED1 47 
R_LED2 110 
R_LED3 110 
MMBT2222ALT1G 
http://www.onsemi.com/pub_link/Collateral/MMBT2222LT1-D.
PDF 
J_oxi, J_LED, 
J_Photo Connectors provided by the soldering lab 
Blood Pressure 
C12 1uf 
C13 2.2uf 
C14 1uf 
C15 0.1uf 
C16 1uf 
R12 15k 
R13 33k 
R14 15k 
R15 1k 
R16 100k 
R19 17.4k 
R20 10k 
C18 270pf 
C19 10uf 
C21 0.1uf 
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C22 0.1uf 
C23 3.3uf 
C24 5600pf 
C25 10uf 
C26 0.1uf 
C27 1uf 
C28 10uf 
R21 1.2k 
R22 10k 
R23 4.7M 
R24 2.7k 
R25 27k 
R26 27k 
R27 14k 
R28 56k 
R29 150k 
MCP6004 http://ww1.microchip.com/downloads/en/DeviceDoc/21733j.pdf 
 
Order Information Links: 
Resistor 
Value Amount 
Resistors 
Cost Per Unit Resistor DigiKey links 
47 1 $0.10 
http://www.digikey.com/product-detail/en/yageo/RC0402JR-0747RL/31
1-47JRCT-ND/729431 
110 2 $0.10 
http://www.digikey.com/product-detail/en/yageo/RC0603JR-07110RL/3
11-110GRCT-ND/729649 
1k 7 $0.10 
http://www.digikey.com/product-detail/en/yageo/RC0402JR-071KL/31
1-1.0KJRCT-ND/729355 
1.2k 2 $0.10 
http://www.digikey.com/product-detail/en/yageo/RC0402JR-071K2L/3
11-1.2KJRCT-ND/729358 
2.7k 2 $0.10 
http://www.digikey.com/product-detail/en/yageo/RC0402JR-072K7L/3
11-2.7KJRCT-ND/729385 
3.3k 2 $0.10 
http://www.digikey.com/product-detail/en/yageo/RC0603FR-073K3L/3
11-3.30KHRCT-ND/730073 
10k 7 $0.10 
http://www.digikey.com/product-detail/en/yageo/RC0402JR-0710KL/3
11-10KJRCT-ND/729365 
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14k 2 $0.10 
http://www.digikey.com/product-detail/en/yageo/RC0402FR-0714KL/3
11-14.0KLRCT-ND/729487 
15k 1 $0.10 
http://www.digikey.com/product-detail/en/panasonic-electronic-compo
nents/ERJ-2RKF1502X/P15.0KLCT-ND/194186 
17.4k 1 $0.10 
http://www.digikey.com/product-detail/en/yageo/RC0402FR-0717K4L/
311-17.4KLRCT-ND/729494 
27k 4 $0.10 
http://www.digikey.com/product-detail/en/yageo/RC0402JR-0727KL/3
11-27KJRCT-ND/729398 
33k 1 $0.10 
http://www.digikey.com/product-detail/en/yageo/RC0402JR-0733KL/3
11-33KJRCT-ND/729415 
56k 2 $0.10 
http://www.digikey.com/product-detail/en/yageo/RC0402JR-0756KL/3
11-56KJRCT-ND/729442 
110k 1 $0.10 
http://www.digikey.com/product-detail/en/yageo/RC0402JR-07110KL/
311-110KJRCT-ND/729366 
150k 2 $0.10 
http://www.digikey.com/product-detail/en/yageo/RC0402JR-07150KL/
311-150KJRCT-ND/729372 
1M 1 $0.10 
http://www.digikey.com/product-detail/en/yageo/RC0402FR-071ML/31
1-1.00MLRCT-ND/729462 
4.7M 4 $0.10 
http://www.digikey.com/product-detail/en/yageo/RC0402JR-074M7L/Y
AG3304CT-ND/5282170 
 
Capacitor 
Value Amount 
Capacitor 
Cost Per Unit Capacitor DigiKey Links 
270pf 2 $0.19 
http://www.digikey.com/product-detail/en/murata-electronics-north-a
merica/GRM1555C1H271FA01D/490-10686-1-ND/5251419 
5600pf 2 $0.32 
http://www.digikey.com/product-detail/en/kemet/C0603C562J5RACT
U/399-7942-1-ND/3471665 
0.1uf 13 $0.10 
http://www.digikey.com/product-detail/en/murata-electronics-north-a
merica/GRM155R71C104KA88J/490-6328-1-ND/3845525 
0.22uf 2 $0.10 
http://www.digikey.com/product-detail/en/taiyo-yuden/JMK063BJ224
MP-F/587-1819-1-ND/1465289 
1uf 4 $0.10 
http://www.digikey.com/product-detail/en/taiyo-yuden/JMK105BJ105
KV-F/587-1231-1-ND/931008 
2.2uf 2 $0.10 
http://www.digikey.com/product-detail/en/murata-electronics-north-a
merica/GRM155R61A225KE95D/490-10451-1-ND/5026361 
3.3uf 2 $0.26 
http://www.digikey.com/product-detail/en/kemet/C0805C335K8PACT
U/399-3129-1-ND/551634 
10uf 10 $0.12 
http://www.digikey.com/product-detail/en/murata-electronics-north-a
merica/GRM155R60G106ME44D/490-10693-1-ND/5251412 
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Appendix G:​ Printed Housing Designs 
 
 
Figure G-1: Device Housing Design 
 
Figure G-2: Device Housing Lid Design 
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Figure G-3: Ear Sensor LED Housing Design 
 
Figure G-4: Ear Sensor Photodiode Housing Design 
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Appendix H: MATLAB and Arduino Code 
 
Arduino Code 
#define Led1 13 
#define Led2 12 
int senRead=5; //The pin from which data is read. 5 for pulse oximeter, 2 for blood pressure. 
int val= 0; 
int i=0;  
int PulseOx[500]; 
int Adata = 0; 
int Bdata = 0; 
int C = 0; 
 
void setup() { 
  pinMode(Led1, OUTPUT); //pin3 Output 
  pinMode(Led2, OUTPUT); //pin2 Output 
  Serial.begin(4800); // reads data at 19200 bits 
 Serial.println("CLEARDATA"); //clears up any data left from previous projects 
  Serial.println("LABEL,Acolumn,Bcolumn,..."); //always write LABEL, so excel knows the 
next things will be the names of the columns (instead of Acolumn you could write Time for 
instance) 
  Serial.println("RESETTIMER"); //resets timer to 0 
} 
void loop() { 
  BlinkLed1(500); 
  BlinkLed2(1000);  
  int val=analogRead(senRead); 
  Serial.println(val); 
} 
 void BlinkLed1 (int interval){ 
   static long prevMill = 0; 
   if (((long)millis() - prevMill) >= interval){  
    prevMill = millis();  
    digitalWrite(Led1, !digitalRead(Led1)); 
  } 
 } 
  void BlinkLed2 (int interval){ 
   static long prevMill = 500; 
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   if ((millis() - prevMill) >= interval){  
    prevMill = millis();  
    digitalWrite(Led2, !digitalRead(Led2)); 
 }  
 
if ( Serial.available() > 0 ) { 
   int Adata = Serial.read(); 
   Serial.print(Adata);  
  } 
  if ( Serial.available () > 0) { 
    int Bdata = Serial.read(); 
    Serial.print(Bdata); 
  } 
  if ( Serial.available () > 0 ) { 
    int C = Serial.read(); 
    Serial.print(C); 
  } 
Serial.print("DATA,TIME,TIMER,"); //writes the time in the first column A and the time since 
the measurements started in column B 
 
} 
 
MATLAB Code 
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Appendix I: Datasheets 
 
 
Figure I-1: Part of Datasheet for Pressure Sensor.  
 
 
Figure I-2: Part of Datasheet for Glucose Photodiode. 
 
 
